vTv Therapeutics (VTVT) Prepaid Assets (2014 - 2026)

vTv Therapeutics (VTVT) reported Prepaid Assets of $521000.0 for Q1 2026, up 353.04% on a YoY basis from $115000.0 in Q1 2025, and down 29.88% sequentially from $743000.0 in Q4 2025.

vTv Therapeutics (VTVT) Prepaid Assets (2014 - 2026) Analysis & Trends

vTv Therapeutics (VTVT) has 13 years of Prepaid Assets data on file, last reported at $521000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Prepaid Assets rose 353.04% year-over-year to $521000.0; the trailing twelve-month figure through Mar 2026 stood at $521000.0 (up 353.04% YoY), and the FY2025 full-year result was $743000.0, down 37.67% from the prior year.
  • Prepaid Assets eased to $521000.0 in Q1 2026, from $743000.0 in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $2.5 million in Q4 2022 to a low of $112000.0 in Q3 2025.
  • A 5-year average of $994705.9 and a median of $1.0 million in 2023 frame the typical range for Prepaid Assets.
  • Across the five-year window, Prepaid Assets tumbled 89.43% in 2025 and jumped 353.04% in 2026, its largest moves.
  • Tracing VTVT's Prepaid Assets over 5 years: stood at $2.5 million in 2022, then sank by 58.85% to $1.0 million in 2023, then climbed by 14.18% to $1.2 million in 2024, then slumped by 37.67% to $743000.0 in 2025, then dropped by 29.88% to $521000.0 in 2026.
  • Business Quant data shows VTVT's Prepaid Assets at $521000.0 in Q1 2026, $743000.0 in Q4 2025, and $112000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 vTv Therapeutics 19.21 Mn 19.21 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 521,000.00
Dec 31, 2025 743,000.00
Sep 30, 2025 112,000.00
Jun 30, 2025 359,000.00
Mar 31, 2025 115,000.00
Dec 31, 2024 1.19 Mn
Sep 30, 2024 1.06 Mn
Jun 30, 2024 303,000.00
Mar 31, 2024 571,000.00
Dec 31, 2023 1.04 Mn
Sep 30, 2023 1.87 Mn
Jun 30, 2023 1.32 Mn
Mar 31, 2023 1.85 Mn
Dec 31, 2022 2.54 Mn
Sep 30, 2022 1.28 Mn
Jun 30, 2022 643,000.00
Mar 31, 2022 1.39 Mn
Dec 31, 2021 2.05 Mn
Sep 30, 2021 1.57 Mn
Jun 30, 2021 313,000.00